Specialty and orphan drugs continue to dominate the development pipeline, and a new report from Optum Rx spotlights three products that payers should be watching. | Specialty and orphan drugs continue ...

By Deena Beasley (Reuters) -CVS Health, which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, a spokesperson told ...

UnitedHealth Group’s pharmacy benefit manager has filed lawsuits in five counties to stop them from including the company in national opioid litigation.

A Connecticut city is suing insulin manufacturers and prescription drug benefit administrators, alleging the companies artificially inflated the price of insulin. The suit by the city of Torrington, ...